section name header

Pronunciation

BILL-beh-ree

Classifications

Therapeutic Classification: ocular agents, vascular agents

Indications

Complementary/Alternative Medicine: This monograph describes a natural or herbal product that is not subject to FDA guidelines for medicines. Patients and clinicians are advised to read package labels carefully to ensure safe and efficacious use.

REMS


Action

  • Anthocyanidins in bilberry have a variety of effects including increased glycosaminoglycans synthesis, decreased vascular permeability, reduced membrane thickness, redistribution of microvascular blood flow, and formation of interstitial fluid.
Therapeutic effects:
  • Decreased inflammation.
  • Decreased edema.
  • Decreased blood glucose.
  • Improved circulation.

Pharmacokinetics

Absorption: Unknown.

Distribution: Unknown.

Metabolism/Excretion: Eliminated by the kidneys.

Half-Life: Unknown.

Time/Action Profile

ROUTEONSETPEAKDURATION
POunknownunknownunknown

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Endo: low blood sugar

GI: diarrhea, upset stomach

Hemat: bleeding, bruising

Interactions

Natural-Drug Products:

Natural-Natural Products:

Route/Dosage

Availability

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Vaccinium myrtillus, Tegens